The FDA is committed to the expanded access program which provides a pathway for patients to gain access to investigational drugs, biologics and medical devices for serious diseases and life-threatening conditions outside of clinical trials when no comparable or satisfactory approved alternative therapy options are available.
from Food and Drug Administration--Press Releases https://ift.tt/2RDRYfo
via IFTTT
No comments:
Post a Comment